283 related articles for article (PubMed ID: 19484742)
21. The Structure of an NDR/LATS Kinase-Mob Complex Reveals a Novel Kinase-Coactivator System and Substrate Docking Mechanism.
Gógl G; Schneider KD; Yeh BJ; Alam N; Nguyen Ba AN; Moses AM; Hetényi C; Reményi A; Weiss EL
PLoS Biol; 2015 May; 13(5):e1002146. PubMed ID: 25966461
[TBL] [Abstract][Full Text] [Related]
22. Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways.
Duhart JC; Raftery LA
Front Cell Dev Biol; 2020; 8():161. PubMed ID: 32266255
[TBL] [Abstract][Full Text] [Related]
23. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
Lei QY; Zhang H; Zhao B; Zha ZY; Bai F; Pei XH; Zhao S; Xiong Y; Guan KL
Mol Cell Biol; 2008 Apr; 28(7):2426-36. PubMed ID: 18227151
[TBL] [Abstract][Full Text] [Related]
24. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
[TBL] [Abstract][Full Text] [Related]
25. Regulators of mammalian Hippo pathway in cancer.
Liu AM; Wong KF; Jiang X; Qiao Y; Luk JM
Biochim Biophys Acta; 2012 Dec; 1826(2):357-64. PubMed ID: 22683405
[TBL] [Abstract][Full Text] [Related]
26. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
[TBL] [Abstract][Full Text] [Related]
27. Identification of the kinase STK25 as an upstream activator of LATS signaling.
Lim S; Hermance N; Mudianto T; Mustaly HM; Mauricio IPM; Vittoria MA; Quinton RJ; Howell BW; Cornils H; Manning AL; Ganem NJ
Nat Commun; 2019 Apr; 10(1):1547. PubMed ID: 30948712
[TBL] [Abstract][Full Text] [Related]
28. Hippo pathway-dependent and -independent roles of RASSF6.
Ikeda M; Kawata A; Nishikawa M; Tateishi Y; Yamaguchi M; Nakagawa K; Hirabayashi S; Bao Y; Hidaka S; Hirata Y; Hata Y
Sci Signal; 2009 Sep; 2(90):ra59. PubMed ID: 19797269
[TBL] [Abstract][Full Text] [Related]
29. Measuring the Kinase Activities of the LATS/NDR Protein Kinases.
Hergovich A
Methods Mol Biol; 2019; 1893():305-317. PubMed ID: 30565143
[TBL] [Abstract][Full Text] [Related]
30. YAP Mediates Hair Cell Regeneration in Balance Organs of Chickens, But LATS Kinases Suppress Its Activity in Mice.
Rudolf MA; Andreeva A; Kozlowski MM; Kim CE; Moskowitz BA; Anaya-Rocha A; Kelley MW; Corwin JT
J Neurosci; 2020 May; 40(20):3915-3932. PubMed ID: 32341094
[TBL] [Abstract][Full Text] [Related]
31. Protein kinases of the Hippo pathway: regulation and substrates.
Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
[TBL] [Abstract][Full Text] [Related]
32. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
33. The role of extracellular biophysical cues in modulating the Hippo-YAP pathway.
Mo JS
BMB Rep; 2017 Feb; 50(2):71-78. PubMed ID: 27916025
[TBL] [Abstract][Full Text] [Related]
34. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
35. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
36. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
37. Mammalian NDR protein kinases: from regulation to a role in centrosome duplication.
Hergovich A; Cornils H; Hemmings BA
Biochim Biophys Acta; 2008 Jan; 1784(1):3-15. PubMed ID: 17881309
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of the mammalian Hippo signaling pathway.
Ji XY; Zhong G; Zhao B
Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
[TBL] [Abstract][Full Text] [Related]
39. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells.
Heidary Arash E; Shiban A; Song S; Attisano L
EMBO Rep; 2017 Mar; 18(3):420-436. PubMed ID: 28183853
[TBL] [Abstract][Full Text] [Related]
40. From cell structure to transcription: Hippo forges a new path.
Edgar BA
Cell; 2006 Jan; 124(2):267-73. PubMed ID: 16439203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
